Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Page 1
Coronary artery bypass graft surgery using the radial artery as a secondary conduit improves patient survival.
Lin J, Cheng W, Czer LS, De Robertis MA, Mirocha J, Ruzza A, Kass RM, Khoynezhad A, Ramzy D, Esmailian F, Trento A. Lin J, et al. Among authors: kass rm. J Am Heart Assoc. 2013 Aug 22;2(4):e000266. doi: 10.1161/JAHA.113.000266. J Am Heart Assoc. 2013. PMID: 23969224 Free PMC article.
BACKGROUND: The clinical benefits of the left internal thoracic artery-to-left anterior descending coronary artery graft are well established in coronary artery bypass graft surgery (CABG). However, limited data are available regarding the long-term outcome of the radial a …
BACKGROUND: The clinical benefits of the left internal thoracic artery-to-left anterior descending coronary artery graft are well establishe …
Antithymocyte globulin induction therapy adjusted for immunologic risk after heart transplantation.
Czer LS, Phan A, Ruzza A, Rafiei M, Setareh-Shenas S, Caceres M, Awad M, Soliman C, Mirocha J, De Robertis M, Kass RM, Trento A. Czer LS, et al. Among authors: kass rm. Transplant Proc. 2013 Jul-Aug;45(6):2393-8. doi: 10.1016/j.transproceed.2013.02.114. Transplant Proc. 2013. PMID: 23953554
CONCLUSIONS: ATG induction therapy (prospectively dose-adjusted for immunologic risk) in low- and high-risk patients results in excellent and equivalent short- and long-term survival rates, with a low incidence of CR and AMR. The use of ATG does not increase rates of CMV i …
CONCLUSIONS: ATG induction therapy (prospectively dose-adjusted for immunologic risk) in low- and high-risk patients results in excellent an …
Aortic valve replacement or heart transplantation in patients with aortic stenosis and severe left ventricular dysfunction.
Czer LS, Goland S, Soukiasian HJ, Gallagher S, De Robertis MA, Mirocha J, Siegel RJ, Kass RM, Trento A. Czer LS, et al. Among authors: kass rm. Transplant Proc. 2013 Jan-Feb;45(1):364-8. doi: 10.1016/j.transproceed.2012.04.032. Epub 2012 Sep 19. Transplant Proc. 2013. PMID: 23267804

In the subsequent analysis of 131 patients, 90-day survivors were followed for a mean 4.6 3.5 years. Advanced age (P = .001) was the only predictor of long-term mortality. LVEF improved from 28.5% 5.2% before AVR to 45.4% 13.2% at 1-month postoperatively (P < .0001). ..

…
In the subsequent analysis of 131 patients, 90-day survivors were followed for a mean 4.6 3.5 years. Advanced age (P = .001) was the only pr …
Coronary revascularization alone or with mitral valve repair: outcomes in patients with moderate ischemic mitral regurgitation.
Goland S, Czer LS, Siegel RJ, DeRobertis MA, Mirocha J, Zivari K, Kass RM, Raissi S, Fontana G, Cheng W, Trento A. Goland S, et al. Among authors: kass rm. Tex Heart Inst J. 2009;36(5):416-24. Tex Heart Inst J. 2009. PMID: 19876417 Free PMC article.
Recurrent (3+ or 4+) mitral regurgitation was found in 22% and 47% at late follow-up, respectively.In patients with moderate ischemic mitral regurgitation, either surgical approach led to an improvement in functional class. Early and intermediate-term mortality rates were …
Recurrent (3+ or 4+) mitral regurgitation was found in 22% and 47% at late follow-up, respectively.In patients with moderate ischemic mitral …
Use of cardiac allografts with mild and moderate left ventricular hypertrophy can be safely used in heart transplantation to expand the donor pool.
Goland S, Czer LS, Kass RM, Siegel RJ, Mirocha J, De Robertis MA, Lee J, Raissi S, Cheng W, Fontana G, Trento A. Goland S, et al. Among authors: kass rm. J Am Coll Cardiol. 2008 Mar 25;51(12):1214-20. doi: 10.1016/j.jacc.2007.11.052. J Am Coll Cardiol. 2008. PMID: 18355661 Free article.
Patients with or without donor LVH had similar 1-year (3.5% vs. 9.5%, p = 0.2) and 5-year survival rates (84 +/- 5.9% vs. 70 +/- 2.7%, p = 0.07). CONCLUSIONS: Short- and long-term survival rates and rates of LVH at follow-up were similar in both groups, suggesting that don …
Patients with or without donor LVH had similar 1-year (3.5% vs. 9.5%, p = 0.2) and 5-year survival rates (84 +/- 5.9% vs. 70 +/- 2.7%, p = 0 …
Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation.
Goland S, Czer LS, Kass RM, De Robertis MA, Mirocha J, Coleman B, Capelli C, Raissi S, Cheng W, Fontana G, Trento A. Goland S, et al. Among authors: kass rm. J Heart Lung Transplant. 2007 Apr;26(4):312-8. doi: 10.1016/j.healun.2006.12.012. Epub 2007 Mar 2. J Heart Lung Transplant. 2007. PMID: 17403470
Patients' PHT did not show a significant difference in 30-day mortality (p = 0.9) and long-term survival (p = 0.8). Patients with residual post-transplant PHT (PVR > or = 3 WU) had reduced long-term survival (p = 0.03). ...CONCLUSIONS: Pre-existing elevated PVR t …
Patients' PHT did not show a significant difference in 30-day mortality (p = 0.9) and long-term survival (p = 0.8). Patients with res …
Risk factors associated with reoperation and mortality in 252 patients after aortic valve replacement for congenitally bicuspid aortic valve disease.
Goland S, Czer LS, De Robertis MA, Mirocha J, Kass RM, Fontana GP, Chang W, Trento A. Goland S, et al. Among authors: kass rm. Ann Thorac Surg. 2007 Mar;83(3):931-7. doi: 10.1016/j.athoracsur.2006.10.047. Ann Thorac Surg. 2007. PMID: 17307436
Patients with moderate aortic dilatation had significantly lower prevalence of coronary artery disease compared with patients with normal ascending aortas (20.5% and 45.4%; p = 0.006). Mean follow-up was 8.9 +/- 6.3 years. Long-term survival was significantly different acr …
Patients with moderate aortic dilatation had significantly lower prevalence of coronary artery disease compared with patients with normal as …
Twenty-year comparison of tissue and mechanical valve replacement.
Khan SS, Trento A, DeRobertis M, Kass RM, Sandhu M, Czer LS, Blanche C, Raissi S, Fontana GP, Cheng W, Chaux A, Matloff JM. Khan SS, et al. Among authors: kass rm. J Thorac Cardiovasc Surg. 2001 Aug;122(2):257-69. doi: 10.1067/mtc.2001.115238. J Thorac Cardiovasc Surg. 2001. PMID: 11479498 Free article.
Analysis by age less than 65 years or 65 years or older and presence or absence of coronary disease revealed similar long-term survival in all subgroups. The risk of hemorrhage was lower in patients receiving tissue aortic valve replacements but was not significantly diffe …
Analysis by age less than 65 years or 65 years or older and presence or absence of coronary disease revealed similar long-term surviv …
Correlation of acute and chronic defibrillation threshold with upper limit of vulnerability determined in normal sinus rhythm.
Birgersdotter-Green U, Undesser K, Fujimura O, Feld GK, Kass RM, Mandel WJ, Peter CT, Chen PS. Birgersdotter-Green U, et al. Among authors: kass rm. J Interv Card Electrophysiol. 1999 Jul;3(2):155-61. doi: 10.1023/a:1009825731592. J Interv Card Electrophysiol. 1999. PMID: 10387143
ULV plus 5J successfully defibrillated 19 of 21 patients. During long-term follow-up of 10.1 +/- 1.8 months in eight patients, DFT was 8.8 +/- 5.8J, not significantly different than the DFT of 7.5 +/- 4.1J or ULV of 8.0 +/- 5.3 at implant. ...Mean ULV at implant was 9.2 +/ …
ULV plus 5J successfully defibrillated 19 of 21 patients. During long-term follow-up of 10.1 +/- 1.8 months in eight patients, DFT wa …
A 20-year experience with the Hancock porcine xenograft in the elderly.
Khan SS, Chaux A, Blanche C, Kass RM, Cheng W, Fontana GP, Trento A. Khan SS, et al. Among authors: kass rm. Ann Thorac Surg. 1998 Dec;66(6 Suppl):S35-9. doi: 10.1016/s0003-4975(98)01027-3. Ann Thorac Surg. 1998. PMID: 9930413
BACKGROUND: The availability of 20 years of follow-up data on the Hancock porcine valve (Medtronic Inc, Irvine, CA) allows determination of long-term actual and actuarial failure rates in the elderly. METHODS: We analyzed outcomes after mitral or aortic valve replacement w …
BACKGROUND: The availability of 20 years of follow-up data on the Hancock porcine valve (Medtronic Inc, Irvine, CA) allows determination of …
14 results